Extra Insights: April 27, 2020

Extra Insights: April 27, 2020

In today’s Cyndx Insights, Miro and Affinax land significant Series B funding. Find more opportunities in the digital collaboration and biotech sectors with Extra Insights, powered by Cyndx Finder.

Digital Collaboration Companies: Demand Means Deals

Stay-at-home guidelines make collaboration services a new necessity for businesses everywhere, and online whiteboard companies like Miro are seeing increased demand. Miro boasts 5 million users, continues to add employees internationally, and recently secured $50M in Series B funding.

Cyndx found over 500 private companies similar to Miro, from well-known Asana (which last year reached $100M in revenue) to the less familar Jell.

Top Companies Similar to Miro: 1. Zillable; 2. Asana; 3. ZiveBox; 4. Jell; 5. Upwave; 6. MindMeister; 7. Systems of Engagement Space; 8. Knotable; 9. Conceptboard
Digital Collaboration Companies Similar to Miro

Biotechnology’s Potential for Big Returns

Biotech meant big deals before COVID-19, and Affinax proved no different last week when it closed $120M in Series B. The Boston-based enterprise joins other vaccine developers like ImmBio, Ltd. in a sector known to net huge returns; the Cyndx platform returned valuation multiples for 80 public companies it deemed closely comparable.

Top Companies Comparable to Affinax: 1. ImmBio Ltd.; 2. Abcombi Biosciences; 3. Emergent BioSolutions; 4. Vaccibody; 5. Bavarian Nordic AS; 5. MabVax Therapeutic Hldgs; 6. Abera Bioscience; 7. Compugen Ltd.
Biotech Companies Similar to Affinax

Looking for investment targets in the digital collaboration or biotech sectors? Contact Cyndx for a free demo of our private company search tools.

Join the thousands of subscribers receiving insights and updates from Cyndx.

Leave a Reply

Your email address will not be published. Required fields are marked *

New Whitepaper

An Efficient Way to Find Relevant Investments Quickly

Download Projected to Raise to learn about Cyndx's proprietary model for identifying which companies will raise capital within the next six months, with 86% precision.